Next Monday Allergan will publish its past quarters results. Over the current book year the total revenue will be 15,81 billion USD (consensus estimates). This is slightly more than 2018's revenue of 15,79 billion USD.
The analysts expect for 2020 a net profit of 5,62 billion USD. According to most of the analysts the company will have a profit per share for this book year of 16,91 USD. The PE-ratio therefore is 11,27.
For this year most of the analysts expect a dividend of 2,97 USD per share. The dividend yield is then 1,56 percent. The average dividend yield of the pharmaceutical companies equals an attractive1,99554907052689 percent.
Based on the current number of outstanding shares Allergan's market capitalization 62,94 billion USD. The Allergan stock was the past 12 months quite volatile. Since last January the stock is even 23 percent higher. This year the stock price moved between 114 and 195 dollar. Since 2008 the stock price is almost 382 percent higher.
Click here for dividend . At 0.30 the stock trades 0 percent lower at 190,6 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.